Business Standard

Saturday, December 21, 2024 | 01:44 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Vivo Bio Tech consolidated net profit declines 57.14% in the September 2022 quarter

Image

Capital Market

Sales rise 24.58% to Rs 12.67 crore

Net profit of Vivo Bio Tech declined 57.14% to Rs 0.12 crore in the quarter ended September 2022 as against Rs 0.28 crore during the previous quarter ended September 2021. Sales rose 24.58% to Rs 12.67 crore in the quarter ended September 2022 as against Rs 10.17 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales12.6710.17 25 OPM %36.7837.76 -PBDT2.882.80 3 PBT0.511.07 -52 NP0.120.28 -57

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 16 2022 | 2:47 PM IST

Explore News